>02_cluster_A47934|8c1052|0-388|118|A47934_46_0336 VanJ peptidoglycan bridge formation proteim FemAB vanK
MSNNSSRALTRTAAGNPVVRPISAADHLAFVRAQRSVSFLQTPAWGRVKTEWRSESLGWFDGPRLVGAGLVLHRPVPRLDRYTLAYLPEGPVIDWSSEIGAWLDPLAAYLKEHGAFAIRLGPPVVTDTWDATQIKDGIADPQIRRLTDMPGRWDDPVGARVSSQLKDAGWLPQNPLDGFGVGHPQFKYVLPLAGRTEDELLRGMNQQWRRNIKKSAKEGVEVTVSDGGPEDLKAFHDLYVHTAERDRFTPRPLSYFETMFTALRAEDPERIKIYLAHHQGDLVAATVMVRVGSHAVYSYGASATAKREVRGSNACQWAMIRDALAADCDVYDLRGITPTLDADDPHVGLVRFKVGTGGQAVRYVGEWDLPLRPMIYRAFDLYMRRRGH
>24_cluster_esnapd26|351c67|0-392|3101|esnapd26_1241_0336 VanJ peptidoglycan bridge formation proteim FemAB vanK
LTGGMSYNSSSEPMRTAAGNPVVRPISAAEHVAFVQAQQSVSFLQTPAWGRVKTEWRSESLGWFVGGRLVGAGLVLHRPVPRFDRFTLAYLPEGPVIDWSGAIGAWLDPLAAYLKEHGAFAIRLGPPVVTDTWSAAQVKEGIADPEIRRLTDVPGQWADPVGARVSSGLKDAGWLPQNPQDGFGVGHPQFKYEVPLAGRTEDELLKGMNQQWRRNIKKAAKEGVEVTVGDGSPEALKAFHDLYVHTAERDRFTPRPLRYFETMFVALSTEDPERIKLYLAHHQGDLVAATILIRVGAHAVYAYGASATAKREVRGSNACQWAMIRDALAADCDVYDLRGITPTLDAADPHVGLVQFKVGTGGRAVRYVGEWDLPLRPMVYRAFDLYMRRRGR
>29_cluster_pekiskomycin|475a81|0-388|3797|pekiskomycin_1551_0336 VanJ peptidoglycan bridge formation proteim FemAB vanK
MSYTPSSQPMRTAAGRLVVRPISAAEHLLFVRAQRSVSFLQTPAWGHVKTEWRNESLGWFDGPRLVGAGLVLHRPVPRLDRFTLAYLPEGPVIDWTGEIDAWLDPLAAYLKEHGAFAIRLGPPVVTDTWSAAQVKEGIAGPDIRRLTDLPAQWSDPVGAHLSSRLKNAGWLPQNPLDGFGVGHPQFKYEVPLAGRTQDELLKGMNQQWRRNIKKAAKEGVEVTVGNQDPEDLKAFHDLYVHTAERDHFTPRPLGYFDTMFAALSAEDPERIKLYLARHQGDLVAATILVRVGTHAVYAYGASATAKREVRGSNACQWAMIRDALAAGCDVYDLRGITPTLDADDSHVGLIQFKVGTGGQAVRYVGEWDLPLRPVVYRVFDLYMKRRGR
>47_cluster_WAC1420|18ee33|0-388|6191|WAC1420_2441_0336 VanJ peptidoglycan bridge formation proteim FemAB vanK
MSINPSSELMRTAAGNPVVRPISDAEHVAFVQAQRSVSFLQTPAWGRVKTEWRSESLGWFLGRRLVGAGLVLHRPVPRLDRYTLAYLPEGPVIDWSGEIGAWLDPLATHLKAQGAFAIRLGPPVRTDAWSAAQVKEGIADPGCKRLTDISGHWSDPVGARVGSKLREAGWLSQSPEDGFGVGHPQFKYEIPMAGRTEDELLKGMNQQWRRNIKKAAKEGVEVTVSDRGAEDLKAFHDLYVHTAERDHFTPRPLRYFETMFAALSAEDPERIKLYMARHQGDLAAATVLVRVGAHAVYAYGASSTAKRDVRGSNACQWAMIRDSLAAGCDVYDLRGITPTLDADDPHVGLVQFKVGTGGQAMRYVGEWDLPLRPMVYRAFGLYMRRRGR
